• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌氨酸脱氢酶通过趋化因子途径在胆囊癌进展中的作用及机制。

Role and mechanism of sarcosine dehydrogenase in the progression of gallbladder cancer through chemokine pathways.

作者信息

Gao Zhen, Zhang Xin, He Hua

机构信息

Department of General Surgery, Qingpu Branch of Zhongshan Hospital, Fudan University, Shanghai 201700, China.

Department of Hepatobiliary Surgery, Pudong Hospital, Fudan University, Shanghai 200433, China.

出版信息

World J Gastrointest Oncol. 2025 Jun 15;17(6):105016. doi: 10.4251/wjgo.v17.i6.105016.

DOI:10.4251/wjgo.v17.i6.105016
PMID:40547148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12179943/
Abstract

BACKGROUND

Sarcosine dehydrogenase () and motif chemokine ligand 1 () have been identified as potential tumor regulators, with growing evidence linking them to cancer progression. However, their specific roles, regulatory mechanisms, and influence on key signaling pathways remain unclear.

AIM

To investigate the regulatory mechanisms of and in cancer cells and their impact on key signaling pathways.

METHODS

Real-time quantitative polymerase chain reaction and western blot analyses were used to assess the expression levels of and and their effects on protein kinase B (Akt) and extracellular signal-regulated kinase (ERK) signaling pathways. Gene overexpression was induced using an expression vector, while gene silencing was achieved using short hairpin RNA and small interfering RNA. CCK-8, migration, and invasion assays were used to evaluate the impact of gene suppression and overexpression on cancer cell proliferation, migration, and invasion.

RESULTS

silencing significantly enhanced cancer cell proliferation, whereas its overexpression suppressed proliferation in the early stages of the experiment. silencing reduced cancer cell migration and invasion. overexpression inhibited cell migration, invasion, and adhesion while increasing apoptosis. Conversely, silencing reversed these effects. Furthermore, simultaneous silencing of and strongly activated the Akt and ERK signaling pathways, indicating the potential role of these pathways in regulating cellular functions influenced by these genes.

CONCLUSION

This study revealed that and regulate cancer cell growth, migration, and invasion through Akt and ERK signaling pathways, highlighting their potential as therapeutic targets for cancer treatment.

摘要

背景

肌氨酸脱氢酶()和基序趋化因子配体1()已被确定为潜在的肿瘤调节因子,越来越多的证据表明它们与癌症进展有关。然而,它们的具体作用、调节机制以及对关键信号通路的影响仍不清楚。

目的

研究和在癌细胞中的调节机制及其对关键信号通路的影响。

方法

采用实时定量聚合酶链反应和蛋白质免疫印迹分析来评估和的表达水平及其对蛋白激酶B(Akt)和细胞外信号调节激酶(ERK)信号通路的影响。使用表达载体诱导基因过表达,同时使用短发夹RNA和小干扰RNA实现基因沉默。采用CCK-8、迁移和侵袭试验来评估基因抑制和过表达对癌细胞增殖、迁移和侵袭的影响。

结果

沉默显著增强癌细胞增殖,而其过表达在实验早期抑制增殖。沉默减少癌细胞迁移和侵袭。过表达抑制细胞迁移、侵袭和黏附,同时增加细胞凋亡。相反,沉默逆转了这些效应。此外,同时沉默和强烈激活Akt和ERK信号通路,表明这些信号通路在调节受这些基因影响的细胞功能中具有潜在作用。

结论

本研究表明和通过Akt和ERK信号通路调节癌细胞的生长、迁移和侵袭,突出了它们作为癌症治疗靶点的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f0/12179943/a57ee391e80b/wjgo-17-6-105016-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f0/12179943/8b4d0d1b2427/wjgo-17-6-105016-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f0/12179943/96ceb94eceba/wjgo-17-6-105016-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f0/12179943/19c931e55074/wjgo-17-6-105016-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f0/12179943/017258a05064/wjgo-17-6-105016-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f0/12179943/36fa6d0df13c/wjgo-17-6-105016-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f0/12179943/a57ee391e80b/wjgo-17-6-105016-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f0/12179943/8b4d0d1b2427/wjgo-17-6-105016-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f0/12179943/96ceb94eceba/wjgo-17-6-105016-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f0/12179943/19c931e55074/wjgo-17-6-105016-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f0/12179943/017258a05064/wjgo-17-6-105016-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f0/12179943/36fa6d0df13c/wjgo-17-6-105016-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f0/12179943/a57ee391e80b/wjgo-17-6-105016-g006.jpg

相似文献

1
Role and mechanism of sarcosine dehydrogenase in the progression of gallbladder cancer through chemokine pathways.肌氨酸脱氢酶通过趋化因子途径在胆囊癌进展中的作用及机制。
World J Gastrointest Oncol. 2025 Jun 15;17(6):105016. doi: 10.4251/wjgo.v17.i6.105016.
2
tRF-Pro-CGG Suppresses Cell Proliferation and Promotes Apoptosis in Pancreatic Cancer.tRF-Pro-CGG抑制胰腺癌细胞增殖并促进其凋亡。
Dig Dis Sci. 2025 Mar 8. doi: 10.1007/s10620-025-08943-x.
3
Understanding mechanisms of -derived exosome-like nanoparticles against breast cancer through an integrated metabolomics and network pharmacology analysis.通过综合代谢组学和网络药理学分析了解源自 - 的外泌体样纳米颗粒抗乳腺癌的机制。
Front Chem. 2025 Jun 6;13:1559758. doi: 10.3389/fchem.2025.1559758. eCollection 2025.
4
circ-NOLC1 inhibits the development of cervical cancer by regulating miR-330-5p-PALM signaling axis.环状非编码RNA NOLC1通过调控miR-330-5p-PALM信号轴抑制宫颈癌的发展。
Hereditas. 2025 Jun 18;162(1):108. doi: 10.1186/s41065-025-00478-5.
5
RSU1 Mediates Caco-2 Colorectal Cancer Cells Proliferation and Migration via PI3K/AKT Signaling Pathway.RSU1通过PI3K/AKT信号通路介导Caco-2结肠癌细胞的增殖和迁移。
Cell Biochem Biophys. 2025 Jun 21. doi: 10.1007/s12013-025-01809-z.
6
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Quinacrine induces autophagy via the Dlg5/AKT pathway to inhibit osteosarcoma cell proliferation and suppresses migration and invasion through the Dlg5/Girdin pathway.奎纳克林通过Dlg5/AKT途径诱导自噬以抑制骨肉瘤细胞增殖,并通过Dlg5/Girdin途径抑制迁移和侵袭。
Phytomedicine. 2025 Jun 12;145:156981. doi: 10.1016/j.phymed.2025.156981.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
10
Cell death-inducing DFF45-like effector C intervenes the progression of non-small cell lung cancer via modulating lipid metabolism.细胞死亡诱导因子DFF45样效应因子C通过调节脂质代谢干预非小细胞肺癌的进展。
Int J Surg. 2025 Jun 24. doi: 10.1097/JS9.0000000000002796.

本文引用的文献

1
Tumor-associated macrophages/C-X-C motif chemokine ligand 1 promotes breast cancer autophagy-mediated chemoresistance via IGF1R/STAT3/HMGB1 signaling.肿瘤相关巨噬细胞/C-X-C 基序趋化因子配体 1 通过 IGF1R/STAT3/HMGB1 信号通路促进乳腺癌自噬介导的化疗耐药性。
Cell Death Dis. 2024 Oct 11;15(10):743. doi: 10.1038/s41419-024-07123-5.
2
Targeting cytokine and chemokine signaling pathways for cancer therapy.针对细胞因子和趋化因子信号通路的癌症治疗。
Signal Transduct Target Ther. 2024 Jul 22;9(1):176. doi: 10.1038/s41392-024-01868-3.
3
DPF2 overexpression correlates with immune infiltration and dismal prognosis in hepatocellular carcinoma.
DPF2过表达与肝细胞癌中的免疫浸润及不良预后相关。
J Cancer. 2024 Jul 2;15(14):4668-4685. doi: 10.7150/jca.97437. eCollection 2024.
4
The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management.促炎细胞因子和 CXC 趋化因子(CXCL1-CXCL16)在前列腺癌进展中的作用:对其治疗管理的深入了解。
Cell Mol Biol Lett. 2024 May 14;29(1):73. doi: 10.1186/s11658-024-00591-9.
5
The role of CXCL1 in crosstalk between endocrine resistant breast cancer and fibroblast.CXCL1 在内分泌耐药乳腺癌与成纤维细胞串扰中的作用。
Mol Biol Rep. 2024 Feb 23;51(1):331. doi: 10.1007/s11033-023-09119-4.
6
The CXCLs-CXCR2 axis modulates the cross-communication between tumor-associated neutrophils and tumor cells in cervical cancer.CXCLs-CXCR2 轴调节宫颈癌中肿瘤相关中性粒细胞与肿瘤细胞的交叉通讯。
Expert Rev Clin Immunol. 2024 May;20(5):559-569. doi: 10.1080/1744666X.2024.2305808. Epub 2024 Jan 24.
7
Sarcosine dehydrogenase as an immune infiltration-associated biomarker for the prognosis of hepatocellular carcinoma.肌氨酸脱氢酶作为肝细胞癌预后的免疫浸润相关生物标志物
J Cancer. 2024 Jan 1;15(1):149-165. doi: 10.7150/jca.89616. eCollection 2024.
8
The Clinical Significance and Role of CXCL1 Chemokine in Gastrointestinal Cancers.CXCL1 趋化因子在胃肠道癌中的临床意义和作用。
Cells. 2023 May 17;12(10):1406. doi: 10.3390/cells12101406.
9
The role of CXCL family members in different diseases.CXCL家族成员在不同疾病中的作用。
Cell Death Discov. 2023 Jul 1;9(1):212. doi: 10.1038/s41420-023-01524-9.
10
Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma.RRM2的过表达预示着与免疫浸润相关的不良预后:一种潜在的肝细胞癌生物标志物。
Front Oncol. 2023 Mar 28;13:1144269. doi: 10.3389/fonc.2023.1144269. eCollection 2023.